Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
APTBIO logo — Cutting-Edge Omics for Your Research.

APTBIO

Cutting-Edge Omics for Your Research.

Founded 2004 Hong Kong S.a.r. Hong Kong S.a.r. 53 employees Series C Total: $428.29M Biotechnology

General Information

Company Name APTBIO
Founded Year 2004
Location Hong Kong S.a.r. Hong Kong S.a.r. +1
Employees 53
Industries Biotechnology
Funding Stage Series C
Social

Get notified when APTBIO moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About APTBIO

APTBIO, with the slogan “Cutting-Edge Omics for Your Research,” is an innovative venture rooted in the biotechnology industry, headquartered in the dynamic hub of Hong Kong S.a.r.. Established in 2004, this company leverages its extensive R&D expertise along with integration of AI big data and advanced mass spectrometry platforms.

APTBIO operates two significant business segments: academic omics services and biopharmaceutical CRO services. Their offerings include specialized services in proteomics, peptidomics, metabolomics, spatial omics, and bioinformatics analysis, catering to academic organizations. The company also provides customized CRO and CMC certification services for the pharmaceutical sector.

In its journey to advance life sciences, APTBIO successfully secured a Series C investment on 08 April 2024, with participation from renowned investors GF Xinde and Sun Rock Capital, underscoring strong investor confidence in their innovative solutions.

Taxonomy: multi-omics solutions, proteomics, peptidomics, metabolomics, spatial omics, bioinformatics analysis, mass spectrometry, academic omics services, biopharmaceutical CRO services, CMC certification, AI big data integration, R&D expertise, protein molecule identification, post-translational modifications

Services & Products

Protein Structure Analysis
Biopharmaceutical Technology Services
Life Sciences Cloud Platform
Early Drug Discovery
Clinical Research Support

Target Customers

Biotechnology Companies Pharmaceutical Researchers Healthcare Providers Academic Research Institutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 3
Investor Investor
•••• •••• 		01 Apr 2024
Series B •••••• 1
Investor
01 Aug 2022
Series A •••••• 2
Investor
•••• •••• 		01 Apr 2020

APTBIO Alternatives & Competitors

View All Alternatives
APTBIO vs
Precision Scientific
Precision Scientific China

Multi-omics Data Driven, Translational Medicine

21 employees
APTBIO vs
Genestack
Genestack United Kingdom

Unlocking the Power of Life Science Data

37 employees
Analytics, Data Analytics
Compare APTBIO vs Genestack
APTBIO vs
Pythia BioSciences
Pythia BioSciences United States

Tackling Top Challenges in Multi-Omics Analysis

25 employees
Also compare with: APTBIO vs Sino Biological, Inc. Sino Biological, Inc. APTBIO vs Biodesix, Inc. Biodesix, Inc. View all alternatives

FAQ About APTBIO

Cutting-Edge Omics for Your Research.
APTBIO was founded in 2004.
APTBIO is headquartered in Hong Kong S.a.r..
APTBIO operates in the following industries: Biotechnology.
APTBIO has approximately 53 employees.
APTBIO has completed 3 funding rounds, raising a total of $428.29M. The latest funding stage is Series C.
APTBIO offers: Protein Structure Analysis, Biopharmaceutical Technology Services, Life Sciences Cloud Platform, Early Drug Discovery, Clinical Research Support.
Top alternatives and competitors to APTBIO include Precision Scientific, Genestack, Pythia BioSciences, Sino Biological, Inc., Biodesix, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
APTBIO and Precision Scientific are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors APTBIO and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy